Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)

NCT03541668 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

674

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischaemic Stroke

Interventions

DRUG: Recombinant human urokinase
DRUG: Alteplase

Sponsor

Tasly Biopharmaceuticals Co., Ltd.